4.7 Article

Rhodium complexes as therapeutic agents

Journal

DALTON TRANSACTIONS
Volume 45, Issue 7, Pages 2762-2771

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/c5dt04338g

Keywords

-

Funding

  1. Hong Kong Baptist University [FRG2/14-15/004]
  2. Health and Medical Research Fund [HMRF/14130522]
  3. Research Grants Council [HKBU/201811, HKBU/204612, HKBU/201913]
  4. French National Research Agency/Research Grants Council Joint Research Scheme [A-HKBU201/12]
  5. National Natural Science Foundation of China [21575121]
  6. Guangdong Province Natural Science Foundation [2015A030313816]
  7. Hong Kong Baptist University Century Club Sponsorship Scheme
  8. Interdisciplinary Research Matching Scheme [RC-IRMS/14-15/06]
  9. Inter-institutional Collaborative Research Scheme [RC-ICRS/15-16/02A]
  10. State Key Laboratory of Synthetic Chemistry
  11. Science and Technology Development Fund, Macao SAR [103/2012/A3]
  12. University of Macau [MYRG091(Y3-L2)-ICMS12-LCH, MYRG2015-00137-ICMS-QRCM, MRG023/LCH/2013/ICMS, MRG044/LCH/2015/ICMS]

Ask authors/readers for more resources

The landscape of inorganic medicinal chemistry has been dominated by the investigation of platinum, and to a lesser extent ruthenium, complexes over the past few decades. Recently, complexes based on other metal centers such as rhodium have attracted attention due to their tunable chemical and biological properties as well as distinct mechanisms of action. This perspective highlights recent examples of rhodium complexes that show diverse biological activities against various targets, including enzymes and protein-protein interactions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available